Thomas Earl Starzl, MD, PhD

Affiliations: 
Thomas E. Starzl Transplantation Institute University of Pittsburgh Medical Center, Pittsburgh, PA, United States 
Google:
"Thomas Starzl"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Starzl TE. (2021) TRANSPLANTATION OF WHOLE HUMAN ORGANS. Proceedings of the American Philosophical Society. 115: 258-266
Denmark SW, Shaw BW, Starzl TE, et al. (2021) VENO-VENOUS BYPASS WITHOUT SYSTEMIC ANTICOAGULATION IN CANINE AND HUMAN LIVER TRANSPLANTATION. Surgical Forum. 34: 380-382
Starzl TE, Groth CG, Brettschneider L. (2021) THE USE OF HETEROLOGOUS ANTILYMPHOCYTE GLOBULIN (ALG) IN HUMAN RENAL AND LIVER TRANSPLANTATION. International Congress Series. 162: 83-90
Brettschneider L, Daloze PM, Huguet C, et al. (2021) SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surgical Forum. 18: 376-378
Starzl TE, Marchioro TL, Faris TD, et al. (2021) The Therapeutic Potential of Whole Organ Transplantation. Journal of the American Medical Women's Association. 21: 207-209
Starzl TE. (2021) The Current Status of Liver Transplantation. Hospital Practice (Hospital Ed.). 6: 47-60
Kashiwagi N, Groth CG, Brettschneider L, et al. (2021) Effect of homograft ischemia upon serum proteins after orthotopic liver transplantation. Surgery. 63: 247-251
Celli S, Valdivia LA, Kelly RH, et al. (2019) Functional cooperation of xenoproteins after hamster-to-rat liver transplantation: With particular reference to hamster C3 and secretory component for rat IgA. Xenotransplantation. 2: 46-51
Starzl TE. (2015) Anthony Cerami Award in Translational Medicine: A Journey in Science: The Birth of Organ Transplantation with Particular Reference to Alloengraftment Mechanisms. Molecular Medicine (Cambridge, Mass.). 21: 227-32
Gandhi CR, Chaillet JR, Nalesnik MA, et al. (2015) Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice. Gastroenterology. 148: 379-391.e4
See more...